Hurley Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Hurley Capital's AMGN Position: Q1 2026 in Review
Hurley Capital reduced its Amgen (AMGN) stake by 69% in Q1 2026, selling an estimated $37.1K and leaving 47 shares worth $16.7K. The position accounts for 0.01% of the portfolio, ranked #287.
Hurley Capital first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $49.5K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Hurley Capital held 47 shares of Amgen worth $16.7K as of Q1 2026.
- Hurley Capital sold 104 Amgen shares in Q1 2026, an estimated $37.1K.
- Amgen made up 0.01% of Hurley Capital's portfolio in Q1 2026, its #287 holding.
- Hurley Capital first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- Hurley Capital's Amgen position peaked at $49.5K in Q4 2025.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.